Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease
| dc.contributor.author | Karamanakos, P. N. | en |
| dc.contributor.author | Pappas, P. | en |
| dc.contributor.author | Marselos, M. | en |
| dc.date.accessioned | 2015-11-24T18:57:48Z | |
| dc.date.available | 2015-11-24T18:57:48Z | |
| dc.identifier.issn | 0928-1231 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19208 | |
| dc.rights | Default Licence | - |
| dc.subject | Animals | en |
| dc.subject | Antiparkinson Agents/*adverse effects | en |
| dc.subject | Chlorpheniramine/*therapeutic use | en |
| dc.subject | Dyskinesia, Drug-Induced/*drug therapy/etiology | en |
| dc.subject | Levodopa/*adverse effects | en |
| dc.subject | Parkinson Disease/*drug therapy | en |
| dc.subject | Serotonin Receptor Agonists/*therapeutic use | en |
| dc.title | Possible role for chlorpheniramine in the treatment of L-DOPA induced dyskinesia in Parkinson's disease | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.primary | 10.1007/s11096-007-9138-7 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/17597418 | - |
| heal.identifier.secondary | http://www.springerlink.com/content/6115214433727j22/fulltext.pdf | - |
| heal.journalName | Pharm World Sci | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2008 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: